BASEL, Switzerland, Jan. 5, 2005 (PRIMEZONE) -- Roche:
2 February 08.00 CET - Morning teleconference 2 February 15.15 GMT - Presentation in London (16.15 CET) 3 February 12.30 EST - Presentation in New York (18.30 CET)
Roche will publish its Full Year Results for 2004 prior to the opening of the Swiss Stock Exchange on February 2 at 07.00 CET (Central European time). Concurrently, the Full Year Presentation, the Annual Report and Sustainability Report will be available from the Roche website http://ir.roche.com. We would like to invite all interested parties to dial in or participate in any of the scheduled events outlined below:
February 2, 2005
The MORNING TELECONFERENCE is being held by senior management followed by a Q&A session at 08.00 CET.
Participants will be:
Dr. Erich Hunziker, CFO and Deputy Head of the Corporate Executive Committee
William M. Burns, CEO Division Roche Pharma
Heino von Prondzynski, CEO Division Roche Diagnostics
Dr. Karl Mahler, Head of Investor Relations
Dial in to the conference 10-15 min prior to the scheduled start using the following numbers:
+41 91 610 5600 (Europe and ROW)
or +44 207 107 06 11 (UK)
or +1 866 291 4166 (USA)
Alternatively, a live audio webcast can be accessed via http://ir.roche.com
The FULL YEAR PRESENTATION followed by Q&A and additional break-out sessions will be held at One Whitehall Place, London, (Gladstone Library, Whitehall Place), starting from 15.15 GMT.
Participants will be:
Dr. Franz B. Humer, Chairman of the Board of Directors and Chief Executive Officer
Dr. Erich Hunziker, CFO and Deputy Head of the Corporate Executive Committee
William M. Burns, CEO Division Roche Pharma
Heino von Prondzynski, CEO Division Roche Diagnostics
This presentation can be followed by a live audio webcast with synchronized presentation slides accessed via http://ir.roche.com. Alternatively, you can dial in to the conference using the following dial-in numbers (listen only mode, no live access to speakers):
+41 91 610 5600 (Europe and ROW)
or +44 207 107 0611 (UK)
or +1 866 291 4166 (USA)
The break-out sessions covering the topics Strategy & Finance, Pharmaceuticals, Diagnostics and Accounting will be held following the main Q&A session.
February 3, 2005
The FULL YEAR PRESENTATION followed by Q&A and additional break-out sessions will be held at Sofitel, New York (45 West, 44th Street), starting from 12.30 EST.
Participants will be:
Dr. Franz B. Humer, Chairman of the Board of Directors and Chief Executive Officer
Dr. Erich Hunziker, CFO and Deputy Head of the Corporate Executive Committee
William M. Burns, CEO Division Roche Pharma
Heino von Prondzynski, CEO Division Roche Diagnostics
Dial in to the conference using the following dial-in numbers (listen only mode, no live access to speakers):
+41 91 610 5600 (Europe and ROW)
or +44 207 107 0611 (UK)
or +1 412 858 4600 (USA)
The break-out sessions (will be repeated once) covering the topics Strategy & Finance, Pharmaceuticals, Diagnostics and Accounting will be held following the main Q&A session.
REPLAYS
Replays will be available one hour after the respective event, for 48 hours. Access is by dialing:
+41 91 612 4330 (Europe)
or +44 207 866 4300 (UK)
or +1 412 317 0088 (USA) and enter the conference ID followed by
the # sign.
Morning teleconference: ID 200
Full Year presentation London: ID 226
Full Year presentation NY: ID 273
All webcasts will be available on demand at http://ir.roche.com. The break-out sessions will be recorded and placed on the Roche website within two business days.
-0- Roche IR Contacts: Dr. Karl Mahler Dr. Zuzana Dobbie Phone: +41 (0)61 687 85 03 Phone: +41 (0)61 688 80 27 e-mail: karl.mahler@roche.com e-mail: zuzana.dobbie@roche.com Dianne Young Eva-Maria Schafer Phone: +41 (0)61 688 93 56 Phone: +41 (0)61 688 66 36 e-mail: dianne.young@roche.com e-mail: eva-maria.schaefer@roche.com North American investors please contact: Richard Simpson Phone: +1 973 235 3655 e-mail: richard.simpson@roche.com